Chris Kirby

Title: Chris Kirby: Innovator in Pharmaceutical Dosage Forms

Introduction

Chris Kirby is a notable inventor based in Reading, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of 2 patents to his name, Kirby's work is recognized for its potential impact on medication administration.

Latest Patents

Kirby's latest patents focus on pharmaceutical dosage forms comprising 6'-fluoro-(N-methyl- or N,N-dimethyl-)-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine. These formulations are designed for administration twice daily, once daily, or less frequently, and include a physiologically acceptable salt of the active ingredient. His innovative approach aims to enhance the effectiveness and convenience of pharmaceutical treatments.

Career Highlights

Throughout his career, Chris Kirby has worked with prominent companies in the pharmaceutical industry, including Gruenenthal GmbH. His experience in these organizations has allowed him to refine his expertise in drug formulation and development.

Collaborations

Some of his notable coworkers include Nadja Gruening and Marc Schiller. Their collaborative efforts have contributed to advancements in pharmaceutical research and development.

Conclusion

Chris Kirby's contributions to pharmaceutical dosage forms demonstrate his commitment to innovation in the field. His patents reflect a dedication to improving medication delivery and patient care.